These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6229379)
1. Reversal of left ventricular hypertrophy with captopril: heterogeneity of response among hypertensive patients. Mujais SK; Fouad FM; Tarazi RC Clin Cardiol; 1983 Dec; 6(12):595-602. PubMed ID: 6229379 [TBL] [Abstract][Full Text] [Related]
2. Alterations in the electrocardiogram of spontaneously hypertensive rats by chronic antihypertensive therapy with captopril. Kleber FX; Pfeffer MA; Pfeffer JM Clin Exp Hypertens A; 1982; 4(6):977-87. PubMed ID: 6212168 [TBL] [Abstract][Full Text] [Related]
3. [Electrocardiographic and echocardiographic changes during antihypertensive therapy]. Sau F; Seguro C; Pili G; Basciu M; Siddi PP; Tamponi R; Cherchi A Cardiologia; 1990 Dec; 35(12):1015-22. PubMed ID: 2151370 [TBL] [Abstract][Full Text] [Related]
4. Regression of left ventricular hypertrophy on long-term treatment with captopril of severe hypertensives refractory to standard triple treatment. de Faire U; Lindvall K; Andersson G; Eriksson S Eur J Clin Pharmacol; 1989; 37(3):291-4. PubMed ID: 2533076 [TBL] [Abstract][Full Text] [Related]
5. Consequences of reversal of hypertensive cardiac hypertrophy by captopril on left ventricular pumping ability and performance. Saragoça MA; Cezaretti ML; Bessa AM; Casarini D; Almeida JB; Amorim MP; Ramos OL J Hypertens Suppl; 1987 Dec; 5(5):S403-6. PubMed ID: 2965226 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular mass and function before and after antihypertensive treatment. Lombardo M; Zaini G; Pastori F; Fusco M; Pacini S; Foppoli C J Hypertens; 1983 Oct; 1(3):215-9. PubMed ID: 6241622 [TBL] [Abstract][Full Text] [Related]
7. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review. Bang CN; Devereux RB; Okin PM J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475 [TBL] [Abstract][Full Text] [Related]
8. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings]. Klaus D Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016 [TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Pfeffer JM; Pfeffer MA; Mirsky I; Braunwald E Proc Natl Acad Sci U S A; 1982 May; 79(10):3310-4. PubMed ID: 6212929 [TBL] [Abstract][Full Text] [Related]
10. Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. Julien J; Dufloux MA; Prasquier R; Chatellier G; Menard D; Plouin PF; Menard J; Corvol P J Am Coll Cardiol; 1990 Jul; 16(1):137-42. PubMed ID: 2141612 [TBL] [Abstract][Full Text] [Related]
11. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy. Liebson PR Am J Hypertens; 1990 Jun; 3(6 Pt 1):512-7. PubMed ID: 2142430 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system. Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675 [TBL] [Abstract][Full Text] [Related]
13. Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Sen S; Tarazi RC; Bumpus FM Hypertension; 1980; 2(2):169-76. PubMed ID: 6445875 [TBL] [Abstract][Full Text] [Related]
14. Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat. Pfeffer JM; Pfeffer MA; Mirsky I; Braunwald E Eur Heart J; 1983 Jan; 4 Suppl A():143-8. PubMed ID: 6220893 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of nitrendipine and captopril on the regression of hypertensive left ventricular hypertrophy. Wang LS; Bai MY Chin Med J (Engl); 1991 Aug; 104(8):645-8. PubMed ID: 1833165 [TBL] [Abstract][Full Text] [Related]
16. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients. Okin PM J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946 [TBL] [Abstract][Full Text] [Related]
17. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure. Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854 [TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. MacMahon S; Collins G; Rautaharju P; Cutler J; Neaton J; Prineas R; Crow R; Stamler J Am J Cardiol; 1989 Jan; 63(3):202-10. PubMed ID: 2521269 [TBL] [Abstract][Full Text] [Related]
19. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study. Okin PM; Devereux RB; Gerdts E; Snapinn SM; Harris KE; Jern S; Kjeldsen SE; Julius S; Edelman JM; Lindholm LH; Dahlöf B; Circulation; 2006 Mar; 113(12):1588-96. PubMed ID: 16534012 [TBL] [Abstract][Full Text] [Related]
20. Effects of long-term blood pressure control on left and right ventricular structure and function in hypertensive patients. Cuspidi C; Sampieri L; Angioni L; Boselli L; Bragato R; Leonetti G; Zanchetti A J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S157-8. PubMed ID: 1715470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]